ScreenerHero

MLAB Mesa Laboratories, Inc.

NAS · US · Technology · Scientific & Technical Instruments · mesalabs.com
142.23USD+7.30%Mkt Cap: 795.90M $P/E: 167.33

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilizatio…

Industry Peers

Scientific & Technical Instruments
Screen all
KEYS
Keysight Technologies, Inc.
$65.40BUSDP/E 52.0
COHR
Coherent Corp.
$65.34BUSDP/E 81.0
COHR
Coherent Corp.
$62.96BUSDP/E 77.8
GRMN
Garmin Ltd.
$55.06BUSDP/E 29.5
GRMN
Garmin Ltd.
$54.06BUSDP/E 28.9
TDY
Teledyne Technologies Incorporated
$28.71BUSDP/E 30.0
HEXA-B
Hexagon AB (publ)
$26.23BUSDP/E 12.5
MKSI
MKS Inc.
$18.97BUSDP/E 44.6
F03
Fortive Corporation
$17.01BUSDP/E 31.5
FTV
Fortive Corporation
$17.49BUSDP/E 30.2
TRMB
Trimble Inc.
$13.71BUSD
CGNX
Cognex Corporation
$10.83BUSDP/E 61.9
ESE
ESCO Technologies Inc.
$7.04BUSDP/E 50.4
ST
Sensata Technologies Holding plc
$6.28BUSDP/E 72.0
IFCN
INFICON Holding AG
$5.49BUSDP/E 61.9
NOVT
Novanta Inc.
$5.70BUSDP/E 95.3
RSW
Renishaw plc
$4.63BUSDP/E 35.7
VNT
Vontier Corporation
$4.31BUSDP/E 13.2
ITRI
Itron, Inc.
$3.84BUSDP/E 14.7
BMI
Badger Meter, Inc.
$3.62BUSDP/E 29.2
HeadlineSourceTime
Older
Mesa Laboratories (MLAB) Q1 2027 Earnings Call Transcript

CEO Kadia highlights execution fixes and debt reduction amid SDC fulfillment challenges.

Motley Fool
Mesa Laboratories, Inc. Q1 2027 Earnings Call Summary

Moby summary of Mesa Laboratories, Inc.'s Q1 2027 earnings call

Moby
Mesa Laboratories Inc (MLAB) (Q1 2027) Earnings Call Highlights: Margin Expansion and Debt ...

Adjusted operating income surges nearly 20% as the company returns to core organic growth and strengthens its balance sheet.

GuruFocus.com
Mesa Laboratories Q1 Earnings Call Highlights

Mesa Laboratories (NASDAQ:MLAB) reported first-quarter fiscal 2027 revenue growth of 1%, improved operating margins and continued debt reduction, while newly appointed President and CEO Siddhartha Kadia outlined plans to address fulfillment issues in its Sterilization and Disinfection Control busine

MarketBeat